Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from COMPASS Pathways plc

3 Shorted Stocks That Could Be Making a Comeback

With the onset of the earnings season, any positive development among heavily shorted stocks EVgo (EVGO), Amyris (AMRS), and COMPASS Pathways (CMPS) might trigger short squeezes to reward their backers. However, their fundamentals could catch up with them and prevent them from delivering sustained risk-adjusted returns once the dust settles.…

StockNews.com · Apr 10, 2023

Compass Pathways Partners With One Mind To Fund Rising Star Awards

Compass Pathways plc (NASDAQ:CMPS) and California-based non-profit organization One Mind partnered to sponsor three “2022 One Mind - COMPASS Rising Stars Awards.”

Benzinga · Apr 20, 2022

Psyched: Third Michigan City Decriminalizes Psychedelics, MindMed Reports $133M Cash Position, Real Brands To Enter The Space

The psychedelics legislative landscape continues to move forward with Hazel Park, Michigan enacting decriminalization measures for naturally-produced psychedelic molecules, becoming the third city in the state to do so after Ann Arbor and Detroit. In Utah, Governor Cox signed a psychedelics research bill into law and positive legislation around psilocybin is continuing…

Benzinga · Mar 29, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

UK: COMPASS Pathways Forms Partnership To Launch Centre For Mental Health Research And Innovation

COMPASS Pathways plc (NASDAQ:CMPS) has announced the formation of a long-term partnership with the South London and Maudsley NHS Foundation Trust (SLaM) and the Institute of Psychiatry, Psychology Neuroscience at King’s College London. The aim of this collaboration is to launch The Centre for Mental Health Research and Innovation, whose…

Benzinga · Mar 24, 2022

COMPASS Pathways Posts Wider Net Loss In Q4, Gives Update On Psilocybin Research

COMPASS Pathways plc (NASDAQ: CMPS) reported its financial results for the fourth quarter and full year 2021 and gave an update on recent progress across its business.

Benzinga · Feb 24, 2022

Two-Thirds Of Physicians Say Psilocybin Therapy Can Help Treatment-Resistant Depression, New Survey Shows

Psilocybin-focused mental health care company COMPASS Pathways plc (NASDAQ: CMPS) and Sermo announced on Wednesday findings from a survey of Sermo physician members that showed two-thirds of doctors surveyed believe psilocybin therapy has potential therapeutic benefit for patients w

Benzinga · Jan 19, 2022

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Psychedelic Spotlight

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.